Floatz logo

Tazemetostat

Enteropathy Associated T Cell Lymphoma

Eric Jacobsen, MDSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Enteropathy Associated T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Eric Jacobsen, MD
Phase 4BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BB
(+)-VINCRISTINE
Eric Jacobsen, MD
Phase 4BB
ETOPOSIDE
City of Hope Medical Center
Phase 4BB
Theprubicin
Ruijin Hospital
Phase 4BB

View all 9 →

Same molecule, other indications

Tazemetostat is also rated in:

non-Hodgkin lymphomaDormant
BB
Indicative ·
70 / 100
View asset →
epithelioid sarcomaDormant
BB
Indicative ·
70 / 100
View asset →
kidney medullary carcinomaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →